Skip to main content

Health and Medicine

Discovery could lead to neutralizing West Nile virus

Dec. 7, 2018—Research led by James Crowe, Jr., could lead to the first effective treatment for this dangerous mosquito-transmitted infection.

Read more


Study tests new vaccine for precancerous cervical cells

Dec. 7, 2018—The study will test the safety of a new cervical cancer vaccine for women who already have a significant presence of precancerous cells.

Read more


Team seeks to create genetic map of worm’s nervous system

Dec. 7, 2018—A complete map of gene expression for the worm may help address broad questions in neuroscience about how gene expression programs establish diverse sets of neurons and how genetic differences contribute to neuronal function in healthy and disease conditions.

Read more


Team spots clue to rare lung and kidney diseases

Dec. 7, 2018—Research led by Billy Hudson has identified an antibody associated with pulmonary-renal syndrome, a rare autoimmune condition.

Read more


Ethnicity proves reliable indicator of what microbes thrive in the gut

Dec. 4, 2018—Changing the gut microbiome to beat illness really does hold great potential, but first scientists must answer what constitutes a healthy gut microbiome and in whom.

Read more


Beta cell biomarker findings may speed diabetes research

Nov. 30, 2018—Researchers at Vanderbilt University Medical Center have identified a biomarker for insulin-producing beta cells. Their finding could lead to improved ways to study and treat diabetes.

Read more


Lung cancer survival signal

Nov. 30, 2018—New research by Jonathan Lehman and Pierre Massion have identfied a bioimarker that suggests poor prognosis for small-cell lung cancer, as well as potential target for new therapies.

Read more


Ethics study explores precision medicine’s risks, rewards

Nov. 30, 2018—Results of the study suggest the prospect of an array of individual and societal benefits to personalized medicine, as well as risks for physical, dignitary, group, economic, psychological and legal harms, many of which may have been over-emphasized or overlooked in the literature.

Read more


NEI grants help bolster glaucoma research efforts

Nov. 30, 2018—Tonia Rex and David Calkins were recently awarded National Eye Institute grants totaling $6.8 million over five years to develop new treatments for optic neuropathies and glaucoma, the leading cause of irreversible blindness.

Read more


Green tea and diabetes

Nov. 30, 2018—A recent study led by Xiao-Ou Shu and colleagues found that green tea drinking was associated with increased risk of type 2 diabetes in Chinese adults, possibly due to the use of pesticides on tea plants--though the researchers call for further study of the exact mechanism.

Read more


Analyzing single-cell landscapes

Nov. 30, 2018—Qi Liu, PhD, Ken Lau, PhD, and colleagues have developed a new tool, sc-UniFrac, to quantify diverse cell types in single-cell studies.

Read more


Parsing diabetic skin infections

Nov. 30, 2018—People with diabetes may be prone to more skin infections due to an overabundance of a compound that controls inflammation in the body.

Read more


Upcoming Events

MORE EVENTS »